Congruence Therapeutics to Present at Multiple Upcoming Investor Conferences By Araceli Richardson|2024-03-27T13:09:34-07:0003.27.2024|News|0 Comments Read More
Congruence Therapeutics to Participate at the 2023 RBC Capital Markets Healthcare Private Company Conference By Araceli Richardson|2023-11-30T13:09:21-08:0011.30.2023|News|0 Comments Read More
Congruence Therapeutics to Participate at the 3rd Annual Needham Private Biotech Company Virtual 1×1 Forum By Araceli Richardson|2023-10-10T13:06:36-07:0010.10.2023|News|0 Comments Read More
Congruence Therapeutics to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference By Araceli Richardson|2023-09-06T05:04:09-07:0009.06.2023|News|0 Comments Read More
Congruence Therapeutics Announces Presentations at the 2023 European and North America CCG UGM & Conferences By Araceli Richardson|2023-05-25T05:05:14-07:0005.25.2023|News|0 Comments Read More
Congruence Therapeutics to Present at Multiple Investor Conferences in May By Araceli Richardson|2023-05-04T13:58:39-07:0005.04.2023|News|0 Comments Read More
Congruence Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference By Araceli Richardson|2023-05-04T13:59:16-07:0004.12.2023|News|0 Comments Read More
Congruence Thérapeutique annonce l’extension de sa ronde de financement de série A, ce qui porte le total des investissements à plus de 65 millions de $ US By Araceli Richardson|2023-07-06T09:54:37-07:0003.06.2023|French News|0 Comments Read More
Congruence Therapeutics Announces Close of Series A Extension, Bringing Total Round to Over US$65 Million By Araceli Richardson|2023-03-06T05:02:41-08:0003.06.2023|News|0 Comments Read More
Congruence Therapeutics to Present at the January 2023 Biotech Showcase in San Francisco By Araceli Richardson|2023-01-29T08:43:59-08:0012.07.2022|News|0 Comments Read More
